RxSight Inc
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$22.2M
Doctors Paid
8,158
Transactions
20,459
2024 Total
$12.3M
Payment Breakdown by Category
Research$7.1M (32.1%)
Consulting$3.3M (14.9%)
Food & Beverage$927,095 (4.2%)
Travel$17,871 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $10.7M | 31 | 48.2% |
| Unspecified | $7.1M | 2,330 | 32.1% |
| Consulting Fee | $3.3M | 571 | 14.9% |
| Food and Beverage | $927,095 | 16,741 | 4.2% |
| Education | $55,766 | 53 | 0.3% |
| Gift | $50,258 | 130 | 0.2% |
| Travel and Lodging | $17,871 | 36 | 0.1% |
| Honoraria | $15,283 | 561 | 0.1% |
| Compensation for serving as faculty or as a speaker for a medical education program | $1,000 | 1 | 0.0% |
| Entertainment | $697.11 | 5 | 0.0% |
Payments by Type
General
$15.0M
18,129 transactions
Research
$7.1M
2,261 transactions
Ownership
$0
69 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study | $5.1M | 34 | 2,032 |
| CLINICAL STUDY TO EVALUATE THE SAFETY AND EFFECTIVENESS OF THE RXSIGHT LIGHT ADJUSTABLE LENS (LAL) IN SUBJECTS DESIRING AN EXTENDED DEPTH OF FOCUS | $1.3M | 15 | 141 |
| Clinical Outcomes of Patients Bilaterally Implanted with the Commercially Available RxSight Light Adjustable Lens (LAL) | $480,500 | 0 | 38 |
| Clinical Outcomes of Patients Implanted with the Commercially Available RxSight Light Adjustable Lens (LAL) | $61,300 | 0 | 17 |
| BINOCULAR CUSTOM VISION UTILIZING THE LIGHT ADJUSTABLE LENS (LAL) | $42,915 | 1 | 1 |
| Clinical Study to Evaluate the Safety and Effectiveness of the RxSight Light Adjustable Lens (LAL) in Subjects With Prior Corneal Refractive Surgery | $31,948 | 13 | 25 |
| CLINICAL OUTCOMES OF PATIENTS IMPLANTED WITH THE RXSIGHT LIGHT ADJUSTABLE LENS (LAL) | $11,200 | 3 | 3 |
| CLINICAL STUDY TO EVALUATE THE SAFETY AND EFFECTIVENESS OF PERFORMING 0.50 DIOPTER ASTIGMATISM CORRECTION ON THE COMMERCIALLY AVAILABLE RXSIGHT LIGHT ADJUSTABLE LENS (LAL) | $9,700 | 2 | 3 |
| ActiveShield US Data Collection PMCS-002 | $3,461 | 1 | 1 |
Payments by Medical Specialty
Top Paid Doctors — Page 3
| Doctor | Specialty | Location | Total | 2023 |
|---|---|---|---|---|
| Alexander Foster, M.d, M.D | Cornea and External Diseases Specialist | Encinitas, CA | $15,421 | $0 |
| Jose Bigles-Geigel, M.d, M.D | Ophthalmology | Covington, GA | $15,181 | $0 |
| Jeffrey Martin, Md, MD | Ophthalmology | Smithtown, NY | $14,965 | $0 |
| Michael Waggoner, Do, DO | Ophthalmology | Rogers, AR | $14,809 | $0 |
| Robert Melendez, M.d, M.D | Ophthalmology | Albuquerque, NM | $14,808 | $0 |
| Dr. Ronald Rebenitsch, M.d, M.D | Ophthalmology | Oklahoma City, OK | $14,496 | $0 |
| Dr. Priya Mathews, M.d, M.D | Ophthalmology | Venice, FL | $13,733 | $0 |
| Jennifer Wong | Student in an Organized Health Care Education/Training Program | San Francisco, CA | $12,812 | $0 |
| Jeffrey Whitman, M.d, M.D | Ophthalmology | Dallas, TX | $12,809 | $0 |
| Ms. Tina Diehl, O.d, O.D | Optometrist | Los Angeles, CA | $12,716 | $0 |
| Neda Shamie, M.d, M.D | Ophthalmology | Los Angeles, CA | $12,273 | $0 |
| Mr. Cory Pickett | Family | Amarillo, TX | $12,180 | $0 |
| Dr. John Stephens, M.d, M.D | Ophthalmology | Cape Coral, FL | $12,180 | $0 |
| Dr. Danny Lin, Md, MD | Ophthalmology | San Francisco, CA | $12,024 | $0 |
| Dr. William Ashford, M.d, M.D | Ophthalmology | Madison, MS | $12,012 | $0 |
| Eva Liang, Md, MD | Ophthalmology | Las Vegas, NV | $11,859 | $0 |
| Dr. Ronald Carr, Od, OD | Optometrist | Orland Park, IL | $11,616 | $0 |
| Brian Szabo, Do, DO | Student in an Organized Health Care Education/Training Program | Tampa, FL | $10,527 | $0 |
| Jeffery Taylor, Md, MD | Ophthalmology | Paducah, KY | $10,295 | $0 |
| Hersh Chopra, M.d, M.D | Ophthalmology | Marietta, GA | $10,232 | $0 |
| Steve Chang, M.d, M.D | Ophthalmology | Reno, NV | $9,259 | $0 |
| Lee Moore, M.d, M.D | Internal Medicine | Madison, MS | $9,115 | $0 |
| James Klein, Md, MD | Ophthalmology | St Clair Shores, MI | $9,067 | $0 |
| Dr. Jack Holladay, M.d, M.D | Specialist | Bellaire, TX | $9,043 | $0 |
| Jason Stahl, Md, MD | Ophthalmology | Overland Park, KS | $9,026 | $0 |
Ad
Top Products
- RXSIGHT CONTACT LENS $16.0M
- LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) $5.8M
Associated Products (4)
Payment Categories
- Food & Beverage $927,095
- Consulting $3.3M
- Travel & Lodging $17,871
- Research $7.1M
About RxSight Inc
RxSight Inc has made $22.2M in payments to 8,158 healthcare providers, recorded across 20,459 transactions in the CMS Open Payments database. In 2024, the company paid $12.3M. The top product by payment volume is RXSIGHT CONTACT LENS ($16.0M).
Payments were distributed across 69 medical specialties. The top specialty by payment amount is Ophthalmology ($15.0M to 3,557 doctors).
Payment categories include: Food & Beverage ($927,095), Consulting ($3.3M), Research ($7.1M), Travel & Lodging ($17,871).
RxSight Inc is associated with 4 products in the CMS Open Payments database, including RXSIGHT CONTACT LENS, LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD), and RXSIGHT INJECTOR HANDPIECE.